カテゴリ： 世界, 医療/バイオ, Market Monitor Global

テルリプレシン注射液のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品

■ 英語タイトル：Terlipressin Injection Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14488）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14488
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[テルリプレシン注射液のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のテルリプレシン注射液市場規模と予測を収録しています。・世界のテルリプレシン注射液市場：売上、2018年-2023年、2024年-2029年
・世界のテルリプレシン注射液市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のテルリプレシン注射液市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「先発医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

テルリプレシン注射液のグローバル主要企業は、Hubei JX Bio Pharmaceutical Co., Ltd.、 Hainan Poly Pharm Co., Ltd.、 Hybio Pharmaceutical Co., Ltd.、 Ferring Pharmaceuticals Co., Ltd.、 Chinese Peptide Co., Ltd.、 EVER Pharma、 Wellona Pharma、 Trumac Healthcare、 Mallinckrodtなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、テルリプレシン注射液のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のテルリプレシン注射液市場：タイプ別、2018年-2023年、2024年-2029年
世界のテルリプレシン注射液市場：タイプ別市場シェア、2022年
・先発医薬品、ジェネリック医薬品

世界のテルリプレシン注射液市場：用途別、2018年-2023年、2024年-2029年
世界のテルリプレシン注射液市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のテルリプレシン注射液市場：地域・国別、2018年-2023年、2024年-2029年
世界のテルリプレシン注射液市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるテルリプレシン注射液のグローバル売上、2018年-2023年
・主要企業におけるテルリプレシン注射液のグローバル売上シェア、2022年
・主要企業におけるテルリプレシン注射液のグローバル販売量、2018年-2023年
・主要企業におけるテルリプレシン注射液のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Hubei JX Bio Pharmaceutical Co., Ltd.、 Hainan Poly Pharm Co., Ltd.、 Hybio Pharmaceutical Co., Ltd.、 Ferring Pharmaceuticals Co., Ltd.、 Chinese Peptide Co., Ltd.、 EVER Pharma、 Wellona Pharma、 Trumac Healthcare、 Mallinckrodt

*************************************************************

・調査・分析レポートの概要
テルリプレシン注射液市場の定義
市場セグメント
世界のテルリプレシン注射液市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のテルリプレシン注射液市場規模
世界のテルリプレシン注射液市場規模：2022年 VS 2029年
世界のテルリプレシン注射液市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのテルリプレシン注射液の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のテルリプレシン注射液製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：先発医薬品、ジェネリック医薬品
テルリプレシン注射液のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
テルリプレシン注射液の用途別グローバル売上・予測

・地域別市場分析
地域別テルリプレシン注射液市場規模 2022年と2029年
地域別テルリプレシン注射液売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Hubei JX Bio Pharmaceutical Co., Ltd.、 Hainan Poly Pharm Co., Ltd.、 Hybio Pharmaceutical Co., Ltd.、 Ferring Pharmaceuticals Co., Ltd.、 Chinese Peptide Co., Ltd.、 EVER Pharma、 Wellona Pharma、 Trumac Healthcare、 Mallinckrodt
...

This research report provides a comprehensive analysis of the Terlipressin Injection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Terlipressin Injection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Terlipressin Injection, challenges faced by the industry, and potential opportunities for market players.
The global Terlipressin Injection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Terlipressin Injection market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Terlipressin Injection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Terlipressin Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Terlipressin Injection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Terlipressin Injection market.
Market Overview: The report provides a comprehensive overview of the Terlipressin Injection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Original Drugs, Generic Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Terlipressin Injection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Terlipressin Injection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Terlipressin Injection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Terlipressin Injection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Terlipressin Injection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Terlipressin Injection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Terlipressin Injection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Terlipressin Injection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Terlipressin Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Original Drugs
Generic Drugs
Market segment by Application
Hospital
Clinic
Other
Global Terlipressin Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Hubei JX Bio Pharmaceutical Co., Ltd.
Hainan Poly Pharm Co., Ltd.
Hybio Pharmaceutical Co., Ltd.
Ferring Pharmaceuticals Co., Ltd.
Chinese Peptide Co., Ltd.
EVER Pharma
Wellona Pharma
Trumac Healthcare
Mallinckrodt
Outline of Major Chapters:
Chapter 1: Introduces the definition of Terlipressin Injection, market overview.
Chapter 2: Global Terlipressin Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Terlipressin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Terlipressin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Terlipressin Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Terlipressin Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Terlipressin Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Terlipressin Injection Overall Market Size
2.1 Global Terlipressin Injection Market Size: 2022 VS 2029
2.2 Global Terlipressin Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Terlipressin Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Terlipressin Injection Players in Global Market
3.2 Top Global Terlipressin Injection Companies Ranked by Revenue
3.3 Global Terlipressin Injection Revenue by Companies
3.4 Global Terlipressin Injection Sales by Companies
3.5 Global Terlipressin Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Terlipressin Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Terlipressin Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Terlipressin Injection Players in Global Market
3.8.1 List of Global Tier 1 Terlipressin Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Terlipressin Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Terlipressin Injection Market Size Markets, 2022 & 2029
4.1.2 Original Drugs
4.1.3 Generic Drugs
4.2 By Type – Global Terlipressin Injection Revenue & Forecasts
4.2.1 By Type – Global Terlipressin Injection Revenue, 2018-2023
4.2.2 By Type – Global Terlipressin Injection Revenue, 2024-2029
4.2.3 By Type – Global Terlipressin Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Terlipressin Injection Sales & Forecasts
4.3.1 By Type – Global Terlipressin Injection Sales, 2018-2023
4.3.2 By Type – Global Terlipressin Injection Sales, 2024-2029
4.3.3 By Type – Global Terlipressin Injection Sales Market Share, 2018-2029
4.4 By Type – Global Terlipressin Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Terlipressin Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Terlipressin Injection Revenue & Forecasts
5.2.1 By Application – Global Terlipressin Injection Revenue, 2018-2023
5.2.2 By Application – Global Terlipressin Injection Revenue, 2024-2029
5.2.3 By Application – Global Terlipressin Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Terlipressin Injection Sales & Forecasts
5.3.1 By Application – Global Terlipressin Injection Sales, 2018-2023
5.3.2 By Application – Global Terlipressin Injection Sales, 2024-2029
5.3.3 By Application – Global Terlipressin Injection Sales Market Share, 2018-2029
5.4 By Application – Global Terlipressin Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Terlipressin Injection Market Size, 2022 & 2029
6.2 By Region – Global Terlipressin Injection Revenue & Forecasts
6.2.1 By Region – Global Terlipressin Injection Revenue, 2018-2023
6.2.2 By Region – Global Terlipressin Injection Revenue, 2024-2029
6.2.3 By Region – Global Terlipressin Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Terlipressin Injection Sales & Forecasts
6.3.1 By Region – Global Terlipressin Injection Sales, 2018-2023
6.3.2 By Region – Global Terlipressin Injection Sales, 2024-2029
6.3.3 By Region – Global Terlipressin Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Terlipressin Injection Revenue, 2018-2029
6.4.2 By Country – North America Terlipressin Injection Sales, 2018-2029
6.4.3 US Terlipressin Injection Market Size, 2018-2029
6.4.4 Canada Terlipressin Injection Market Size, 2018-2029
6.4.5 Mexico Terlipressin Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Terlipressin Injection Revenue, 2018-2029
6.5.2 By Country – Europe Terlipressin Injection Sales, 2018-2029
6.5.3 Germany Terlipressin Injection Market Size, 2018-2029
6.5.4 France Terlipressin Injection Market Size, 2018-2029
6.5.5 U.K. Terlipressin Injection Market Size, 2018-2029
6.5.6 Italy Terlipressin Injection Market Size, 2018-2029
6.5.7 Russia Terlipressin Injection Market Size, 2018-2029
6.5.8 Nordic Countries Terlipressin Injection Market Size, 2018-2029
6.5.9 Benelux Terlipressin Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Terlipressin Injection Revenue, 2018-2029
6.6.2 By Region – Asia Terlipressin Injection Sales, 2018-2029
6.6.3 China Terlipressin Injection Market Size, 2018-2029
6.6.4 Japan Terlipressin Injection Market Size, 2018-2029
6.6.5 South Korea Terlipressin Injection Market Size, 2018-2029
6.6.6 Southeast Asia Terlipressin Injection Market Size, 2018-2029
6.6.7 India Terlipressin Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Terlipressin Injection Revenue, 2018-2029
6.7.2 By Country – South America Terlipressin Injection Sales, 2018-2029
6.7.3 Brazil Terlipressin Injection Market Size, 2018-2029
6.7.4 Argentina Terlipressin Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Terlipressin Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Terlipressin Injection Sales, 2018-2029
6.8.3 Turkey Terlipressin Injection Market Size, 2018-2029
6.8.4 Israel Terlipressin Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Terlipressin Injection Market Size, 2018-2029
6.8.6 UAE Terlipressin Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Hubei JX Bio Pharmaceutical Co., Ltd.
7.1.1 Hubei JX Bio Pharmaceutical Co., Ltd. Company Summary
7.1.2 Hubei JX Bio Pharmaceutical Co., Ltd. Business Overview
7.1.3 Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Major Product Offerings
7.1.4 Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.1.5 Hubei JX Bio Pharmaceutical Co., Ltd. Key News & Latest Developments
7.2 Hainan Poly Pharm Co., Ltd.
7.2.1 Hainan Poly Pharm Co., Ltd. Company Summary
7.2.2 Hainan Poly Pharm Co., Ltd. Business Overview
7.2.3 Hainan Poly Pharm Co., Ltd. Terlipressin Injection Major Product Offerings
7.2.4 Hainan Poly Pharm Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.2.5 Hainan Poly Pharm Co., Ltd. Key News & Latest Developments
7.3 Hybio Pharmaceutical Co., Ltd.
7.3.1 Hybio Pharmaceutical Co., Ltd. Company Summary
7.3.2 Hybio Pharmaceutical Co., Ltd. Business Overview
7.3.3 Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Major Product Offerings
7.3.4 Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.3.5 Hybio Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 Ferring Pharmaceuticals Co., Ltd.
7.4.1 Ferring Pharmaceuticals Co., Ltd. Company Summary
7.4.2 Ferring Pharmaceuticals Co., Ltd. Business Overview
7.4.3 Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Major Product Offerings
7.4.4 Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.4.5 Ferring Pharmaceuticals Co., Ltd. Key News & Latest Developments
7.5 Chinese Peptide Co., Ltd.
7.5.1 Chinese Peptide Co., Ltd. Company Summary
7.5.2 Chinese Peptide Co., Ltd. Business Overview
7.5.3 Chinese Peptide Co., Ltd. Terlipressin Injection Major Product Offerings
7.5.4 Chinese Peptide Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.5.5 Chinese Peptide Co., Ltd. Key News & Latest Developments
7.6 EVER Pharma
7.6.1 EVER Pharma Company Summary
7.6.2 EVER Pharma Business Overview
7.6.3 EVER Pharma Terlipressin Injection Major Product Offerings
7.6.4 EVER Pharma Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.6.5 EVER Pharma Key News & Latest Developments
7.7 Wellona Pharma
7.7.1 Wellona Pharma Company Summary
7.7.2 Wellona Pharma Business Overview
7.7.3 Wellona Pharma Terlipressin Injection Major Product Offerings
7.7.4 Wellona Pharma Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.7.5 Wellona Pharma Key News & Latest Developments
7.8 Trumac Healthcare
7.8.1 Trumac Healthcare Company Summary
7.8.2 Trumac Healthcare Business Overview
7.8.3 Trumac Healthcare Terlipressin Injection Major Product Offerings
7.8.4 Trumac Healthcare Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.8.5 Trumac Healthcare Key News & Latest Developments
7.9 Mallinckrodt
7.9.1 Mallinckrodt Company Summary
7.9.2 Mallinckrodt Business Overview
7.9.3 Mallinckrodt Terlipressin Injection Major Product Offerings
7.9.4 Mallinckrodt Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.9.5 Mallinckrodt Key News & Latest Developments
8 Global Terlipressin Injection Production Capacity, Analysis
8.1 Global Terlipressin Injection Production Capacity, 2018-2029
8.2 Terlipressin Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Terlipressin Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Terlipressin Injection Supply Chain Analysis
10.1 Terlipressin Injection Industry Value Chain
10.2 Terlipressin Injection Upstream Market
10.3 Terlipressin Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Terlipressin Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Terlipressin Injection in Global Market
Table 2. Top Terlipressin Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Terlipressin Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Terlipressin Injection Revenue Share by Companies, 2018-2023
Table 5. Global Terlipressin Injection Sales by Companies, (K Units), 2018-2023
Table 6. Global Terlipressin Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Terlipressin Injection Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Terlipressin Injection Product Type
Table 9. List of Global Tier 1 Terlipressin Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Terlipressin Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Terlipressin Injection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Terlipressin Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Terlipressin Injection Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Terlipressin Injection Sales (K Units), 2018-2023
Table 15. By Type - Global Terlipressin Injection Sales (K Units), 2024-2029
Table 16. By Application – Global Terlipressin Injection Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Terlipressin Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Terlipressin Injection Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Terlipressin Injection Sales (K Units), 2018-2023
Table 20. By Application - Global Terlipressin Injection Sales (K Units), 2024-2029
Table 21. By Region – Global Terlipressin Injection Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Terlipressin Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Terlipressin Injection Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Terlipressin Injection Sales (K Units), 2018-2023
Table 25. By Region - Global Terlipressin Injection Sales (K Units), 2024-2029
Table 26. By Country - North America Terlipressin Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Terlipressin Injection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Terlipressin Injection Sales, (K Units), 2018-2023
Table 29. By Country - North America Terlipressin Injection Sales, (K Units), 2024-2029
Table 30. By Country - Europe Terlipressin Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Terlipressin Injection Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Terlipressin Injection Sales, (K Units), 2018-2023
Table 33. By Country - Europe Terlipressin Injection Sales, (K Units), 2024-2029
Table 34. By Region - Asia Terlipressin Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Terlipressin Injection Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Terlipressin Injection Sales, (K Units), 2018-2023
Table 37. By Region - Asia Terlipressin Injection Sales, (K Units), 2024-2029
Table 38. By Country - South America Terlipressin Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Terlipressin Injection Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Terlipressin Injection Sales, (K Units), 2018-2023
Table 41. By Country - South America Terlipressin Injection Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Terlipressin Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Terlipressin Injection Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Terlipressin Injection Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Terlipressin Injection Sales, (K Units), 2024-2029
Table 46. Hubei JX Bio Pharmaceutical Co., Ltd. Company Summary
Table 47. Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Product Offerings
Table 48. Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Hubei JX Bio Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 50. Hainan Poly Pharm Co., Ltd. Company Summary
Table 51. Hainan Poly Pharm Co., Ltd. Terlipressin Injection Product Offerings
Table 52. Hainan Poly Pharm Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Hainan Poly Pharm Co., Ltd. Key News & Latest Developments
Table 54. Hybio Pharmaceutical Co., Ltd. Company Summary
Table 55. Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Product Offerings
Table 56. Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Hybio Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 58. Ferring Pharmaceuticals Co., Ltd. Company Summary
Table 59. Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Product Offerings
Table 60. Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Ferring Pharmaceuticals Co., Ltd. Key News & Latest Developments
Table 62. Chinese Peptide Co., Ltd. Company Summary
Table 63. Chinese Peptide Co., Ltd. Terlipressin Injection Product Offerings
Table 64. Chinese Peptide Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Chinese Peptide Co., Ltd. Key News & Latest Developments
Table 66. EVER Pharma Company Summary
Table 67. EVER Pharma Terlipressin Injection Product Offerings
Table 68. EVER Pharma Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. EVER Pharma Key News & Latest Developments
Table 70. Wellona Pharma Company Summary
Table 71. Wellona Pharma Terlipressin Injection Product Offerings
Table 72. Wellona Pharma Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Wellona Pharma Key News & Latest Developments
Table 74. Trumac Healthcare Company Summary
Table 75. Trumac Healthcare Terlipressin Injection Product Offerings
Table 76. Trumac Healthcare Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Trumac Healthcare Key News & Latest Developments
Table 78. Mallinckrodt Company Summary
Table 79. Mallinckrodt Terlipressin Injection Product Offerings
Table 80. Mallinckrodt Terlipressin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Mallinckrodt Key News & Latest Developments
Table 82. Terlipressin Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Terlipressin Injection Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Terlipressin Injection Production by Region, 2018-2023 (K Units)
Table 85. Global Terlipressin Injection Production by Region, 2024-2029 (K Units)
Table 86. Terlipressin Injection Market Opportunities & Trends in Global Market
Table 87. Terlipressin Injection Market Drivers in Global Market
Table 88. Terlipressin Injection Market Restraints in Global Market
Table 89. Terlipressin Injection Raw Materials
Table 90. Terlipressin Injection Raw Materials Suppliers in Global Market
Table 91. Typical Terlipressin Injection Downstream
Table 92. Terlipressin Injection Downstream Clients in Global Market
Table 93. Terlipressin Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Terlipressin Injection Segment by Type in 2022
Figure 2. Terlipressin Injection Segment by Application in 2022
Figure 3. Global Terlipressin Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Terlipressin Injection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Terlipressin Injection Revenue, 2018-2029 (US$, Mn)
Figure 7. Terlipressin Injection Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Terlipressin Injection Revenue in 2022
Figure 9. By Type - Global Terlipressin Injection Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Terlipressin Injection Revenue Market Share, 2018-2029
Figure 11. By Type - Global Terlipressin Injection Sales Market Share, 2018-2029
Figure 12. By Type - Global Terlipressin Injection Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Terlipressin Injection Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Terlipressin Injection Revenue Market Share, 2018-2029
Figure 15. By Application - Global Terlipressin Injection Sales Market Share, 2018-2029
Figure 16. By Application - Global Terlipressin Injection Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Terlipressin Injection Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Terlipressin Injection Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Terlipressin Injection Revenue Market Share, 2018-2029
Figure 20. By Region - Global Terlipressin Injection Sales Market Share, 2018-2029
Figure 21. By Country - North America Terlipressin Injection Revenue Market Share, 2018-2029
Figure 22. By Country - North America Terlipressin Injection Sales Market Share, 2018-2029
Figure 23. US Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Terlipressin Injection Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Terlipressin Injection Sales Market Share, 2018-2029
Figure 28. Germany Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 29. France Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Terlipressin Injection Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Terlipressin Injection Sales Market Share, 2018-2029
Figure 37. China Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 41. India Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Terlipressin Injection Revenue Market Share, 2018-2029
Figure 43. By Country - South America Terlipressin Injection Sales Market Share, 2018-2029
Figure 44. Brazil Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Terlipressin Injection Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Terlipressin Injection Sales Market Share, 2018-2029
Figure 48. Turkey Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Terlipressin Injection Revenue, (US$, Mn), 2018-2029
Figure 52. Global Terlipressin Injection Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Terlipressin Injection by Region, 2022 VS 2029
Figure 54. Terlipressin Injection Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • テジゾリドリン酸塩注射剤のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • パクリタキセル注射（アルブミン結合）のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • フェノフィブラートカプセルのグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • 尿路感染症（UTI）治療薬のグローバル市場展望 2023年-2029年：ジェネリック医薬品、先発医薬品
  • ポサコナゾール遅延放出錠のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14488 )"テルリプレシン注射液のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品" (英文：Terlipressin Injection Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。